10-Q: U.S. Physical Therapy Q1 2026 Financial Results

U.S. Physical Therapy reports Q1 2026 net revenue of $198.3 million, up 7.9% year-over-year, despite a decline in net income attributable to shareholders.

Summary

• Net revenue for Q1 2026 was $198.3 million, a 7.9% increase from $183.8 million in Q1 2025.
• Net income attributable to USPH shareholders was $5.0 million, compared to $9.9 million in the prior-year period.
• Basic and diluted loss per share was $0.12, compared to earnings per share of $0.80 in Q1 2025.
• Total owned and/or managed clinics reached 783 as of March 31, 2026.
• The company completed a regional realignment of reporting units effective January 1, 2026.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral report; while top-line growth and clinic expansion are positive, the significant decline in net income and EPS, coupled with increased corporate costs, tempers the outlook.

Positives

• Net revenue grew 7.9% year-over-year to $198.3 million.
• Physical therapy patient visits increased 6.9% to 1,543,144.
• Industrial Injury Prevention (IIP) segment revenue grew 11.8% to $30.6 million.
• Successfully closed a new $450 million credit facility maturing in 2031, providing increased liquidity.
• Announced two 10-year strategic alliances with hospital systems in New York.

Negatives

• Net income attributable to USPH shareholders fell 49.1% to $5.0 million.
• Operating income declined 36.5% to $12.5 million, impacted by a $2.0 million loss on contingent earn-out consideration.
• Corporate office costs increased 12.5% to $18.3 million due to integration and system upgrade costs.
• Reported a loss per share of $0.12, driven by the revaluation of redeemable non-controlling interests.

Risks

• Potential for future Medicare reimbursement rate reductions and regulatory changes.
• Exposure to interest rate volatility on variable-rate debt.
• Risks associated with the integration of newly acquired businesses and potential goodwill impairment.
• Dependence on hiring and retaining qualified physical therapists in a competitive labor market.
• Legal and regulatory risks, including potential qui tam lawsuits and government investigations.

Future Outlook

The company plans to continue its strategy of acquiring multi-clinic outpatient physical therapy practices and IIP businesses, while developing satellite clinics. It expects implementation costs for new financial and HR systems to continue through the end of 2026.

Management Comments

• Management noted that the regional realignment was administrative in nature to enhance coordination and operational efficiency.
• Management emphasized that the new $450 million credit facility provides sufficient liquidity for working capital and future growth opportunities.

Industry Context

StockSavvy.ai notes that U.S. Physical Therapy continues to consolidate a fragmented outpatient rehabilitation market. The shift toward hospital-affiliated networks is a strategic move to secure referral pipelines, aligning with broader industry trends of health system integration.

Comparison to Industry Standards

• Revenue growth of 7.9% remains consistent with the company's historical performance in a competitive outpatient therapy landscape.
• The company's use of partnership models with local therapists remains a distinct differentiator compared to larger, fully-owned national chains.
• The reliance on Medicare reimbursement rates aligns with industry-wide exposure to CMS fee schedule adjustments.

Management Changes

Corporate Governance

Legal Proceedings

• The company is a party to various ordinary course legal actions and regulatory audits.
• The company remains subject to potential qui tam lawsuits under the federal False Claims Act.

Related Party Transactions

• The company leases properties from Michael G. Mayrsohn, President of Metro and a member of the Board of Directors.

Stakeholder Impact

• Shareholders: Impacted by lower net income and EPS, but supported by continued dividend payments.
• Employees: Ongoing integration of new acquisitions may impact operational workflows.
• Creditors: Benefit from the new $450 million credit facility with extended maturity.

Next Steps

• Continue integration of newly acquired IIP and physical therapy businesses.
• Complete search for a permanent Chief Financial Officer.
• Continue implementation of new financial and human resources systems through 2026.

Key Dates

Recommendation

The stock is a hold due to the company's strong revenue growth and successful expansion strategy, balanced against the current earnings pressure and management transition at the CFO level.

Keywords

physical therapy, healthcare services, industrial injury prevention, outpatient clinics, USPH, rehabilitation, medical management